Finance

Lists
Outlook: 75.0% bullish·0.0% bearish
Go to analysis
THC:NYSE
Tenet Healthcare Corp
257,60 $
-0,11%
(-0,29) 1D
257,60 $
0,00% (0,00)
After hours
Closed: 29 սեպ, 16:00:03 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for THC...
Open
257,41 $
High
259,89 $
Low
254,21 $
Mkt. cap
20,74 մլրդ
Avg. vol.
794,94 հզր
Volume
448,11 հզր
P/E ratio
9,93
52-wk high
283,05 $
52-wk low
157,58 $
EPS
25,93 $
Beta
1,23
Shares outstanding
80,52 մլն
No. of employees
88 հզր
Open
257,41 $
High
259,89 $
Low
254,21 $
Mkt. cap
20,74 մլրդ
Avg. vol.
794,94 հզր
Volume
448,11 հզր
P/E ratio
9,93
52-wk high
283,05 $
52-wk low
157,58 $
EPS
25,93 $
Beta
1,23
Shares outstanding
80,52 մլն
No. of employees
88 հզր
News stories
From web sources and news partners
Profile
Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International, the company operates around 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients. Since its founding in 1969, Tenet has expanded significantly. Among other major acquisitions and formations, Tenet founded Conifer Health Solutions in 2008, MedPost Urgent Care in 2014, and in 2013 acquired Vanguard Health Systems, Inc., an investor-owned hospital company whose operations complemented Tenet's existing business. The acquisition created the third-largest investor-owned hospital company in the United States in terms of revenue and the third-largest in number of hospitals owned. In 2015, Tenet acquired USPI, which created the largest operator of outpatient surgery centers in the U.S. In 2021, the company ranked 167th in the Fortune 500. Wikipedia
About Tenet Healthcare Corp
CEOSaum Sutaria
Employees88,5 հզր
Founded1969
HeadquartersԴալաս, Տեխաս, Միացյալ Նահանգներ
SectorHealth care provider
Analyst ratings
Based on 18 analysts giving stock ratings to THC in the past 3 months
Strong buy
Buy
16
Hold
2
Sell
0
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for THC in the last 3 months.
Highest
Current 257,60 $
315,00 $ (+22,28%)
Average
283,41 $ (+10,02%)
Lowest
245,00 $ (-4,89%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Cooper
Raymond James
Buy
Reiterated
285,00 $
+10,6%
09/28/2026
Sean Dodge
BMO Capital
Hold
Initiated
265,00 $
+2,9%
09/22/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
-
-
09/17/2026
Craig Hettenbach
Morgan Stanley
Buy
Maintained
274,00 $
+6,4%
09/14/2026
Benjamin Rossi
J.P. Morgan
Buy
Maintained
315,00 $
+22,3%
09/01/2026
A.J. Rice
UBS
Buy
Maintained
308,00 $
+19,6%
08/25/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
290,00 $
+12,6%
08/10/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
295,00 $
+14,5%
08/10/2026
Stephen Baxter
Wells Fargo
Buy
Reiterated
281,00 $
+9,1%
07/31/2026
Scott Fidel
Goldman Sachs
Buy
Reiterated
305,00 $
+18,4%
07/29/2026
Jason Cassorla
Guggenheim
Buy
Maintained
283,00 $
+9,9%
07/27/2026
Michael Ha
Robert W. Baird
Hold
Maintained
280,00 $
+8,7%
07/28/2026
Unknown Analyst
Stephens
Buy
Maintained
285,00 $
+10,6%
07/27/2026
Raj Kumar CFA
Stephens
Buy
Maintained
285,00 $
+10,6%
07/27/2026
David S Macdonald
Truist Financial
Buy
Reiterated
290,00 $
+12,6%
07/28/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
283,00 $
+9,9%
07/26/2026
Ryan Langston
TD Cowen
Buy
Reiterated
263,00 $
+2,1%
07/27/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
245,00 $
-4,9%
07/23/2026
Andrew Mok CFA
Barclays
Buy
Maintained
271,00 $
+5,2%
07/24/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
225,00 $
-12,7%
05/01/2026
Last report
24 հլս, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (USD)
6,12 $ / 4,26 $
+43,54%beat
Revenue / Est. (USD)
5,63 մլրդ / 5,44 մլրդ
+3,53%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
5,29 մլրդ
5,53 մլրդ
5,37 մլրդ
5,63 մլրդ
Cost of goods sold
3,14 մլրդ
3,23 մլրդ
3,14 մլրդ
3,22 մլրդ
Cost of revenue
3,14 մլրդ
3,23 մլրդ
3,14 մլրդ
3,22 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
102,00 մլն
410,00 մլն
102,00 մլն
104,00 մլն
Operating expense
1,34 մլրդ
1,33 մլրդ
1,27 մլրդ
1,39 մլրդ
Total operating expenses
4,47 մլրդ
4,56 մլրդ
4,40 մլրդ
4,61 մլրդ
Operating income
815,00 մլն
965,00 մլն
963,00 մլն
1,02 մլրդ
Other non operating income
31,00 մլն
39,00 մլն
43,00 մլն
45,00 մլն
EBT including unusual items
712,00 մլն
681,00 մլն
1,13 մլրդ
1,34 մլրդ
EBT excluding unusual items
704,00 մլն
882,00 մլն
852,00 մլն
928,00 մլն
Income tax expense
133,00 մլն
37,00 մլն
226,00 մլն
295,00 մլն
Effective tax rate
18,68%
5,43%
19,96%
22,01%
Other operating expenses
1,02 մլրդ
687,00 մլն
937,00 մլն
1,07 մլրդ
Net income
342,00 մլն
371,00 մլն
702,00 մլն
826,00 մլն
Net profit margin
6,47%
6,71%
13,08%
14,68%
Earnings per share
3,70
4,70
4,82
6,12
Interest and investment income
-
-
-
-
Interest expense
-206,00 մլն
-205,00 մլն
-205,00 մլն
-204,00 մլն
Net interest expenses
-206,00 մլն
-205,00 մլն
-205,00 մլն
-204,00 մլն
Depreciation and amortization charges
218,00 մլն
231,00 մլն
229,00 մլն
215,00 մլն
EBITDA
1,03 մլրդ
1,20 մլրդ
1,19 մլրդ
1,24 մլրդ
Gain or loss from assets sale
-20,00 մլն
5,00 մլն
-1,00 մլն
-33,00 մլն
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps